Effect of Treatment With Stress-Doses Glucocorticoid in Patients With Acute Respiratory Distress Syndrome (ARDS)
NCT ID: NCT00773058
Last Updated: 2009-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
100 participants
INTERVENTIONAL
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparative Study of Glucocorticoids Efficacy in Acute Respiratory Distress Syndrome
NCT06496997
HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
NCT05354778
Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)
NCT01763853
ALI/ARDS Clinical Sub-phenotyping Study
NCT06123962
The Effect of Erythropoietin on Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome
NCT05857891
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
glucocorticoid+RAI
stress-dose glucocorticoid treatment, compared to placebo group and ACTH test hints RAI
hydrocortisone
hydrocortisone 100mg q8h
placebo + RAI
no glucocorticoid But ATCH test hints RAI
placebo
normal saline 100ml q8h
glucocorticoid
stress-dose glucocorticoid treatment, compared to placebo group and ACTH test does not hint RAI
hydrocortisone
hydrocortisone 100mg q8h
placebo
no glucocorticoid But ATCH test does not hint RAI
placebo
normal saline 100ml q8h
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hydrocortisone
hydrocortisone 100mg q8h
placebo
normal saline 100ml q8h
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 to 85 year old
Exclusion Criteria
* tumor or other immunologic disease
* immunosuppressive drug used
* bone marrow or lung transplantation
* primary or secondary disease of adrenal gland
* hormone used within 3 months
* refusing conventional therapy
* be in other clinical tests within 30 days
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanjing Medical University
OTHER
Southeast University, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chinese Medical Association
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QHB-YY 2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.